Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.

The use of (18)F-fluorodeoxyglucose positron emission tomography ((18)F-FDG-PET) in the field of oncology is rapidly evolving; however, (18)F-FDG is not tumor specific. Aside from physiological uptake (18)F-FDG also may accumulate in benign processes. Knowledge of these (18)F-FDG-avid nonmalignant lesions is essential for accurate PET interpretation in oncologic patients to avoid a false-positive interpretation. Through the systematic review of the reports of PET/computed tomography (CT) studies performed in oncologic patients during a 6-month period, we found benign nonphysiological uptake of (18)F-FDG in more than 25% of studies. In half of these, (18)F-FDG uptake was moderate or marked in intensity, similar to that of malignant sites. A total of 73% of benign lesions were inflammatory in nature, with post-traumatic bone and soft-tissue abnormalities (including iatrogenic injury) and benign tumors accounting for the remainder. The differentiation of benign from malignant uptake of (18)F-FDG on PET alone may be particularly challenging as a result of the low anatomical resolution of PET and paucity of anatomical landmarks. Fusion imaging, namely PET/CT, has been shown to improve not only the sensitivity of PET interpretation but also its specificity. Aside from better anatomical localization of lesions on PET/CT, morphological characterization of lesions on CT often may improve the diagnostic accuracy of nonspecific (18)F-FDG uptake. Correlation with CT on fused PET/CT data may obviate the need for further evaluation or biopsy in more than one-third of scintigraphic equivocal lesions. Familiarity with (18)F-FDG-avid nonmalignant lesions also may extend the use of (18)F-FDG-PET imaging beyond the field of oncology. We have tabulated our experience with benign entities associated with increased (18)F-FDG uptake on whole-body PET/CT from 12,000 whole-body (18)F-FDG-PET/CT studies performed during a 4-year period.

[1]  Roland Hustinx,et al.  18F-FDG PET imaging of rheumatoid knee synovitis correlates with dynamic magnetic resonance and sonographic assessments as well as with the serum level of metalloproteinase-3 , 2006, European Journal of Nuclear Medicine and Molecular Imaging.

[2]  T. Yen,et al.  False positive fluorine-18 fluorodeoxy-D-glucose positron emission tomography finding caused by osteoradionecrosis in a nasopharyngeal carcinoma patient. , 2004, The British journal of radiology.

[3]  Kyung-Han Lee,et al.  Augmented 18 F-FDG Uptake in Activated Monocytes Occurs During the Priming Process and Involves Tyrosine Kinases and Protein Kinase C , 2003 .

[4]  S. Robbins,et al.  Pathologic basis of disease , 1974 .

[5]  P C Goodman,et al.  Pulmonary drug toxicity: radiologic and pathologic manifestations. , 2000, Radiographics : a review publication of the Radiological Society of North America, Inc.

[6]  R. Hustinx,et al.  Assessment of disease activity in rheumatoid arthritis with (18)F-FDG PET. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[7]  J. Delaney,et al.  Computed tomography of neutropenic colitis. , 1984, AJR. American journal of roentgenology.

[8]  L. Cinotti,et al.  Exogenous lipoid pneumonia with unusual CT pattern and FDG positron emission tomography scan findings , 2002, European Radiology.

[9]  David A Lynch,et al.  Idiopathic interstitial pneumonias: CT features. , 2005, Radiology.

[10]  T Ido,et al.  Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[11]  Atif J. Khan,et al.  Positron emission tomography demonstrates radiation-induced changes to nonirradiated lungs in lung cancer patients treated with radiation and chemotherapy. , 2005, Chest.

[12]  N. Müller,et al.  Cryptogenic organizing pneumonia: CT findings in 43 patients. , 1994, AJR. American journal of roentgenology.

[13]  G. Hutchins,et al.  Diagnosis of lipoid pneumonia by computed tomography. , 1981, JAMA.

[14]  C HIRSCH,et al.  [Arthroplasty of hip]. , 1957, Nordisk medicin.

[15]  Thomas F Hany,et al.  FDG PET for differentiation of infection and aseptic loosening in total hip replacements: comparison with conventional radiography and three-phase bone scintigraphy. , 2004, Radiology.

[16]  K. W. Warren,et al.  Pyogenic hepatic abscess. , 1968, Archives of surgery.

[17]  J. Doppman,et al.  Pituitary microadenomas: a PET study. , 1990, Radiology.

[18]  T. Ogino,et al.  Hibernomas show intense accumulation of FDG positron emission tomography. , 2006, Journal of computer assisted tomography.

[19]  Kyung-Han Lee,et al.  Augmented 18F-FDG uptake in activated monocytes occurs during the priming process and involves tyrosine kinases and protein kinase C. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[20]  M. Graham,et al.  FDG positron emission tomographic imaging of thoracic Castleman's disease. , 2003, Clinical nuclear medicine.

[21]  U. Metser,et al.  Solid splenic masses: evaluation with 18F-FDG PET/CT. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[22]  S. Canale,et al.  Campbell's operative orthopaedics , 1987 .

[23]  E. Balthazar.  Acute pancreatitis: assessment of severity with clinical and CT evaluation. , 2002, Radiology.

[24]  O. Prante,et al.  Uptake of [18F]fluorodeoxyglucose in human monocyte-macrophages in vitro , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[25]  S. A. Khonsary,et al.  Idiopathic Pulmonary Fibrosis: Evaluation with Positron Emission Tomography , 2006, Respiration.

[26]  H. Shinomiya,et al.  Endotoxin-Induced Enhancement of Glucose Influx into Murine Peritoneal Macrophages via GLUT1 , 1995 .

[27]  U. Buell,et al.  Side-by-side reading of PET and CT scans in oncology: which patients might profit from integrated PET/CT? , 2004, European Journal of Nuclear Medicine and Molecular Imaging.

[28]  N. Nishiumi,et al.  18F-FDG PET detection of colonic adenomas. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[29]  K. Horton,et al.  CT findings in sclerosing mesenteritis (panniculitis): spectrum of disease. , 2003, Radiographics : a review publication of the Radiological Society of North America, Inc.

[30]  A. Buck,et al.  Whole-body PET: physiological and artifactual fluorodeoxyglucose accumulations. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[31]  C. Van de Wiele,et al.  Fluorine-18 Fluorodeoxyglucose-Positron Emission Tomography: A Highly Accurate Imaging Modality for the Diagnosis of Chronic Musculoskeletal Infections , 2001 .

[32]  Byung-Tae Kim,et al.  Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging. , 2005, Radiology.

[33]  J. Walsh.  Computed tomography of gynecologic neoplasms. , 1992, Radiologic clinics of North America.

[34]  J Aoki,et al.  FDG PET of primary benign and malignant bone tumors: standardized uptake value in 52 lesions. , 2001, Radiology.

[35]  J. Cardot,et al.  FDG-PET/CT scan of inflammatory spondylodiscitis lesions in ankylosing spondylitis, and short term evolution during anti-tumour necrosis factor treatment , 2005, Annals of the rheumatic diseases.

[36]  J. Babb,et al.  Diffuse FDG shoulder uptake on PET is associated with clinical findings of osteoarthritis. , 2005, AJR. American journal of roentgenology.

[37]  C. Gunnlaugsson.  Head and Neck Surgery-Otolaryngology, 3rd ed , 2002 .

[38]  B. Barlogie,et al.  18F-fluorodeoxyglucose positron emission tomography contributes to the diagnosis and management of infections in patients with multiple myeloma: a study of 165 infectious episodes. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[39]  S. Reske,et al.  Grading of tumors and tumorlike lesions of bone: evaluation by FDG PET. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[40]  R. Parry,et al.  T-lymphocyte activation , 2005 .

[41]  山田 嘉仁.  Fluorine-18-fluorodeoxyglucose and carbon-11-methionine evaluation of lymphadenopathy in sarcoidosis , 1999 .

[42]  A. Fischman,et al.  False-positive FDG positron emission tomography uptake in nonmalignant chest abnormalities. , 2004, AJR. American journal of roentgenology.

[43]  A. Fischman,et al.  Lipomatous hypertrophy of the interatrial septum: increased uptake on FDG PET. , 2005, AJR. American journal of roentgenology.

[44]  B. J. Bailey,et al.  Head and Neck Surgery--Otolaryngology , 1999 .

[45]  L. Donnelly,et al.  Acute graft-versus-host disease in children: abdominal CT findings. , 1996, Radiology.

[46]  Christian Schindler,et al.  The value of [18F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease , 2005, European Journal of Nuclear Medicine and Molecular Imaging.

[47]  S. Schmidt,et al.  Occult lung infarction may induce false interpretation of 18F-FDG PET in primary staging of pulmonary malignancies , 2005, European Journal of Nuclear Medicine and Molecular Imaging.

[48]  Ur Metser,et al.  Benign nonphysiologic lesions with increased 18F-FDG uptake on PET/CT: characterization and incidence. , 2007, AJR. American journal of roentgenology.

[49]  A. Buck,et al.  Brown adipose tissue: a factor to consider in symmetrical tracer uptake in the neck and upper chest region , 2002, European Journal of Nuclear Medicine and Molecular Imaging.

[50]  P Grenier,et al.  Pulmonary histiocytosis X: evaluation with high-resolution CT. , 1989, Radiology.

[51]  V. Bettinardi,et al.  Value of integrated PET/CT for lesion localisation in cancer patients: a comparative study , 2004, European Journal of Nuclear Medicine and Molecular Imaging.

[52]  Wolfgang A Weber,et al.  Use of PET for monitoring cancer therapy and for predicting outcome. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[53]  H. Pohl,et al.  Acute pyelonephritis: comparison of diagnosis with 99mTc-DMSA, SPECT, spiral CT, MR imaging, and power Doppler US in an experimental pig model. , 2001, Radiology.

[54]  J. Wittenberg,et al.  Primary epiploic appendagitis: evolutionary changes in CT appearance. , 1997, Radiology.

[55]  O. Hoekstra,et al.  Accessory findings on F-18 FDG positron emission tomography in bronchogenic carcinoma. , 2003, Clinical nuclear medicine.

[56]  Thomas Beyer,et al.  Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[57]  I. Ak,et al.  F-18 FDG pet in detecting renal cell carcinoma , 2005, Acta radiologica.

[58]  A. Maes,et al.  Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: evidence for inflammation of the aortic arch. , 2000, The American journal of medicine.

[59]  P. Mergo,et al.  MR imaging of inflammatory disease of the liver. , 1997, Magnetic resonance imaging clinics of North America.

[60]  U. Metser,et al.  Mesenteric panniculitis in oncologic patients: PET-CT findings. , 2006, The British journal of radiology.

[61]  P. Eysel,et al.  The implications of 18F-FDG PET for the diagnosis of endoprosthetic loosening and infection in hip and knee arthroplasty: Results from a prospective, blinded study , 2006, BMC musculoskeletal disorders.

[62]  B. Babior.  The respiratory burst of phagocytes. , 1984, The Journal of clinical investigation.

[63]  D. Heron,et al.  Posttreatment assessment of response using FDG-PET/CT for patients treated with definitive radiation therapy for head and neck cancers. , 2006, International journal of radiation oncology, biology, physics.

[64]  W. Hayes,et al.  From the Archives of the AFIP. Xanthogranulomatous pyelonephritis. , 1991, Radiographics : a review publication of the Radiological Society of North America, Inc.

[65]  J. Bading,et al.  Incidental colonic fluorodeoxyglucose uptake: correlation with colonoscopic and histopathologic findings. , 2002, Radiology.

[66]  K. Ishii,et al.  Aortic wall inflammation due to Takayasu arteritis imaged with 18F-FDG PET coregistered with enhanced CT. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[67]  Christopher A Swingle,et al.  Xanthogranulomatous pyelonephritis characterized on PET/CT. , 2005, Clinical nuclear medicine.

[68]  K. Lillemoe,et al.  Pyogenic hepatic abscess. Changing trends over 42 years. , 1996, Annals of surgery.

[69]  Walsh Jw.  Computed tomography of gynecologic neoplasms. , 1992 .

[70]  U. Metser,et al.  18F-FDG PET/CT in the evaluation of adrenal masses. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[71]  J. Shepard,et al.  FDG PET of Rosai-Dorfman disease of the thymus. , 2004, AJR. American journal of roentgenology.

[72]  E. Fishman,et al.  CT evaluation of amyloidosis: spectrum of disease. , 1993, Radiographics : a review publication of the Radiological Society of North America, Inc.

[73]  M. Schweitzer,et al.  MR imaging of the diabetic foot. , 2004, Radiologic clinics of North America.

[74]  U. Metser,et al.  Tumor Lesion Detection: When Is Integrated Positron Emission Tomography/Computed Tomography More Accurate Than Side-by-Side Interpretation of Positron Emission Tomography and Computed Tomography? , 2005, Journal of computer assisted tomography.

[75]  Z. Keidar,et al.  THE DIABETIC FOOT: INITIAL EXPERIENCE WITH FDG-PET/CT , 2006 .

[76]  R. Gamelli,et al.  Augmentations of glucose uptake and glucose transporter‐1 in macrophages following thermal injury and sepsis in mice , 1996, Journal of leukocyte biology.

[77]  A. Brunelli,et al.  Paraneoplastic syndromes in 68 cases of resectable non-small cell lung carcinoma: can they help in early detection? , 1999, Medical oncology.